Business
Why the Bionomics (ASX:BNO) share price surged 8% higher today
The Bionomics Ltd (ASX: BNO) share price has run higher today after the company announced it has entered an agreement to licence its oncology drug candidate, BNC101, to Carina Biotech. At the market’s close, the Bionomics share price had surged 8.33% to 13 cents.
What’s pushing the Bionomics share price?
The Bionomics share price has marched higher today after the company advised that it will exclusively licence BNC101 to Carina. The agreement will see the development of Chimeric Antigen Receptor T-cell (CAR-T) therapy using Bionomics’ flagship drug. CAR-T is known to harness the body’s immune system to fight against cancer.
According to the company, BNC101 is a high-quality, humanised monoclonal antibody to LGR5, which…
-
Noosa News6 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
General16 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General19 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
General18 hours agoGold Coast and Noosa councils scammed out of ratepayers’ money